The effect of cross-sex hormonal treatment on gender dysphoria individuals’ mental health: A systematic review

Neuropsychiatric Disease and Treatment

Volumn 12, Issue , 2016, Pages 1953-1966

  Costa, Rosalia ^a   Colizzi, Marco ^b  

^a TAVISTOCK CLINIC   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Estrogen; Psychiatry; Psychosocial wellbeing; Testosterone; Transsexualism

Indexed keywords

ANXIETY; BODY IMAGE; COMORBIDITY; CROSS SEX HORMONAL TREATMENT; DEPRESSION; DISSOCIATION; EMOTIONALITY; EVIDENCE BASED MEDICINE; GENDER DYSPHORIA; HORMONAL THERAPY; HUMAN; MENTAL HEALTH; MENTAL STRESS; OUTCOME ASSESSMENT; QUALITY OF LIFE; REVIEW; SELF ESTEEM; SEX DIFFERENCE; SOCIAL PSYCHOLOGY; SOCIAL STRESS; SYSTEMATIC REVIEW; TENSION; THERAPY EFFECT; WELLBEING;

EID: 84983461911     PISSN: None     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S95310     Document Type: Review

References (49)

1. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders: DSM-III. 3rd ed. Washington, DC: American Psychiatric Association; 1980.
2. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders: DSM-5. 5th ed. Arlington, VA: American Psychiatric Association; 2013.
3. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders: DSM-IV. 4th ed. Washington, DC: American Psychiatric Association; 1994.
4. American Psychiatric Association (APA). Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. 4th ed. Washington, DC: American Psychiatric Association; 2000.
5. Drescher J. Queer diagnoses: parallels and contrasts in the history of homosexuality, gender variance, and the diagnostic and statistical manual. Arch Sex Behav. 2010;39(2):427-460.
6. à Campo J, Nijman H, Merckelbach H, Evers C. Psychiatric comorbidity of gender identity disorders: a survey among Dutch psychiatrists. Am J Psychiatry. 2003;160(7):1332-1336.
7. Hepp U, Kraemer B, Schnyder U, Miller N, Delsignore A. Psychiatric comorbidity in gender identity disorder. J Psychosom Res. 2005;58(3):259-261.
8. Heylens G, Elaut E, Kreukels BP, et al. Psychiatric characteristics in transsexual individuals: multicentre study in four European countries. Br J Psychiatry. 2014;204(2):151-156.
9. Gómez-Gil E, Trilla A, Salamero M, Godás T, Valdés M. Sociodemographic, clinical, and psychiatric characteristics of transsexuals from Spain. Arch Sex Behav. 2009;38(3):378-392.
10. Hoshiai M, Matsumoto Y, Sato T, et al. Psychiatric comorbidity among patients with gender identity disorder. Psychiatry Clin Neurosci. 2010;64(5):514-519.
11. Fisher AD, Bandini E, Casale H, et al. Sociodemographic and clinical features of gender identity disorder: an Italian multicentric evaluation. J Sex Med. 2013;10(2):408-419.
12. Dhejne C, Van Vlerken R, Heylens G, Arcelus J. Mental health and gender dysphoria: a review of the literature. Int Rev Psychiatry. 2016;28(1):44-57.
13. Sohn M, Bosinski HA. Gender identity disorders: diagnostic and surgical aspects. J Sex Med. 2007;4(5):1193-1207.
14. Colizzi M, Costa R, Pace V, Todarello O. Hormonal treatment reduces psychobiological distress in gender identity disorder, independently of the attachment style. J Sex Med. 2013;10(12):3049-3058.
15. Byne W, Bradley SJ, Coleman E, et al. Report of the American Psychiatric Association task force on treatment of gender identity disorder. Arch Sex Behav. 2012;41(4):759-796.
16. Cohen-Kettenis PT, van Goozen SH. Sex reassignment of adolescent transsexuals: a follow-up study. J Am Acad Child Adolesc Psychiatry. 1997;36(2):262-271.
17. Rehman J, Lazer S, Benet AE, Schaefer LC, Melman A. The reported sex and surgery satisfactions of 28 postoperative male-to-female transsexual patients. Arch Sex Behav. 1999;28(1):71-89.
18. Lawrence AA. Factors associated with satisfaction or regret following male-to-female sex reassignment surgery. Arch Sex Behav. 2003;32(4):299-315.
19. Bodlund O, Armelius K. Self-image and personality traits in gender identity disorders: an empirical study. J Sex Marital Ther. 1994;20(4):303-317.
20. Wolfradt U, Neumann K. Depersonalization, self-esteem and body image in male-to-female transsexuals compared to male and female controls. Arch Sex Behav. 2001;30(3):301-310.
21. Kraemer B, Delsignore A, Schnyder U, Hepp U. Body image and transsexualism. Psychopathology. 2008;41(2):96-100.
22. Weyers S, Elaut E, De Sutter P, et al. Long-term assessment of the physical, mental, and sexual health among transsexual women. J Sex Med. 2009;6(3):752-760.
23. Rakic Z, Starcevic V, Maric J, Kelin K. The outcome of sex reassignment surgery in Belgrade: 32 patients of both sexes. Arch Sex Behav. 1996;25(5):515-525.
24. Newfield E, Hart S, Dibble S, Kohler L. Female-to-male transgender quality of life. Qual Life Res. 2006;15(9):1447-1457.
25. Kuhn A, Bodmer C, Stadlmayr W, Kuhn P, Mueller MD, Birkhäuser M. Quality of life 15 years after sex reassignment surgery for transsexualism. Fertil Steril. 2009;92(5):1685-1689.
26. Ainsworth TA, Spiegel JH. Quality of life of individuals with and without facial feminization surgery or gender reassignment surgery. Qual Life Res. 2010;19(7):1019-1024.
27. Murad MH, Elamin MB, Garcia MZ, et al. Hormonal therapy and sex reassignment: a systematic review and meta-analysis of quality of life and psychosocial outcomes. Clin Endocrinol (Oxf). 2010;72(2):214-231.
28. Slabbekoorn D, van Goozen SH, Megens J, Gooren LJ, Cohen-Kettenis PT. Activating effects of cross-sex hormones on cognitive functioning: a study of short-term and long-term hormone effects in transsexuals. Psychoneuroendocrinology. 1999;24(4):423-447.
29. Miles C, Green R, Hines M. Estrogen treatment effects on cognition, memory and mood in male-to-female transsexuals. Horm Behav. 2006;50(5):708-717.
30. Leavitt F, Berger JC, Hoeppner JA, Northrop G. Presurgical adjustment in male transsexuals with and without hormonal treatment. J Nerv Ment Dis. 1980;168(11):693-697.
31. Slabbekoorn D, Goozen SHV, Gooren LJ, Cohen-Kettenis PT. Effects of cross-sex hormone treatment on emotionality in transsexuals. Int J Transgend. 2001;5(3):2-18.
32. Kuiper B, Cohen-Kettenis P. Sex reassignment surgery: a study of 141 Dutch transsexuals. Arch Sex Behav. 1988;17(5):439-457.
33. West S, King TS, Carey KN, et al. Systems to rate the strength of scientific evidence. Evid Rep Technol Assess (Summ). 2002;47:1-11.
34. Blanchard R, Clemmensen LH, Steiner BW. Gender reorientation and psychosocial adjustment in male-to-female transsexuals. Arch Sex Behav. 1983;12(6):503-509.
35. Gómez-Gil E, Zubiaurre-Elorza L, Esteva I, et al. Hormone-treated transsexuals report less social distress, anxiety and depression. Psychoneuroendocrinology. 2012;37(5):662-670.
36. Gorin-Lazard A, Baumstarck K, Boyer L, et al. Hormonal therapy is associated with better self-esteem, mood, and quality of life in transsexuals. J Nerv Ment Dis. 2013;201(11):996-1000.
37. Colizzi M, Costa R, Todarello O. Transsexual patients’ psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: results from a longitudinal study. Psychoneuroendocrinology. 2014;39:65-73.
38. Bouman WP, Claes L, Marshall E, et al. Sociodemographic variables, clinical features, and the role of preassessment cross-sex hormones in older trans people. J Sex Med. 2016;13(4):711-719.
39. Fisher AD, Castellini G, Bandini E, et al. Cross-sex hormonal treatment and body uneasiness in individuals with gender dysphoria. J Sex Med. 2014;11(3):709-719.
40. Heylens G, Verroken C, De Cock S, T’Sjoen G, De Cuypere G. Effects of different steps in gender reassignment therapy on psychopathology: a prospective study of persons with a gender identity disorder. J Sex Med. 2014;11(1):119-126.
41. Gómez-Gil E, Vidal-Hagemeijer A, Salamero M. MMPI-2 characteristics of transsexuals requesting sex reassignment: comparison of patients in prehormonal and presurgical phases. J Pers Assess. 2008;90(4):368-374.
42. Bonierbale M, Baumstarck K, Maquigneau A, et al. MMPI-2 profile of French transsexuals: the role of sociodemographic and clinical factors. A cross-sectional design. Sci Rep. 2016;6:24281.
43. Gorin-Lazard A, Baumstarck K, Boyer L, et al. Is hormonal therapy associated with better quality of life in transsexuals? A cross sectional study. J Sex Med. 2012;9(2):531-541.
44. Gómez-Gil E, Zubiaurre-Elorza L, de Antonio IE, Guillamon A, Salamero M. Determinants of quality of life in Spanish transsexuals attending a gender unit before genital sex reassignment surgery. Qual Life Res. 2014;23(2):669-676.
45. Colizzi M, Costa R, Todarello O. Dissociative symptoms in individuals with gender dysphoria: is the elevated prevalence real? Psychiatry Res. 2015;226(1):173-180.
46. Asscheman H, Gooren LJ, Eklund PL. Mortality and morbidity in transsexual patients with cross-gender hormone treatment. Metabolism. 1989;38(9):869-873.
47. Su TP, Pagliaro M, Schmidt PJ, Pickar D, Wolkowitz O, Rubinow DR. Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA. 1993;269(21):2760-2764.
48. King JA, Rosal MC, Ma Y, Reed G. Association of stress, hostility and plasma testosterone levels. Neuro Endocrinol Lett. 2005;26(4):355-360.
49. Wylie K, Knudson G, Khan SI, Bonierbale M, Watanyusakul S, Baral S. Serving transgender people: clinical care considerations and service delivery models in transgender health. Lancet. Epub 2016 Jun 16.